We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$42.6B
AUM Growth
-$927M
Cap. Flow
-$4.42B
Cap. Flow %
-10.38%
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$244M
2
PFE icon
Pfizer
PFE
+$234M
3
NKE icon
Nike
NKE
+$201M
4
TSLA icon
Tesla
TSLA
+$200M
5
SPGI icon
S&P Global
SPGI
+$196M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 11.63%
3 Consumer Discretionary 11.09%
4 Financials 10.76%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APYX icon
2976
Apyx Medical
APYX
$131M
-22,788
Closed -$59.7K
AQMS icon
2977
Aqua Metals
AQMS
$10M
-58
Closed -$8.82K
ARES icon
2978
Ares Management
ARES
$31.7B
-13,300
Closed -$1.58M
ARKQ icon
2979
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.92B
-7,100
Closed -$410K
ARLO icon
2980
Arlo Technologies
ARLO
$1.41B
-33,708
Closed -$321K
ARRY icon
2981
Array Technologies
ARRY
$701M
-31,600
Closed -$531K
ASC icon
2982
Ardmore Shipping
ASC
$744M
-142,351
Closed -$2.01M
ASH icon
2983
Ashland
ASH
$3.39B
-7,065
Closed -$596K
ASHR icon
2984
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
-900,060
Closed -$21.5M
ASMB icon
2985
Assembly Biosciences
ASMB
$731M
-11,254
Closed -$111K
ASML icon
2986
ASML
ASML
$673B
-2,300
Closed -$1.74M
ATAT icon
2987
Atour Lifestyle Holdings
ATAT
$4.75B
-82,692
Closed -$1.44M
ATLC icon
2988
Atlanticus Holdings
ATLC
$1.45B
-6,223
Closed -$241K
ATMC
2989
DELISTED
AlphaTime Acquisition Corp
ATMC
-70,257
Closed -$754K
ATRA icon
2990
Atara Biotherapeutics
ATRA
$95.7M
-5,167
Closed -$66.2K
AUPH icon
2991
Aurinia Pharmaceuticals
AUPH
$2.2B
-173,600
Closed -$1.56M
AVAH icon
2992
Aveanna Healthcare
AVAH
$2.98B
-13,900
Closed -$37.3K
AVNW icon
2993
Aviat Networks
AVNW
$267M
-41,232
Closed -$1.35M
AZZ icon
2994
AZZ Inc
AZZ
$4.21B
-12,787
Closed -$743K
BA icon
2995
Boeing
BA
$166B
-108,423
Closed -$28.3M
BABA icon
2996
Alibaba
BABA
$285B
-348,088
Closed -$27M
BAP icon
2997
Credicorp
BAP
$30.1B
-7,702
Closed -$1.15M
BAYAR
2998
DELISTED
Bayview Acquisition Corp Right
BAYAR
-150,000
Closed -$18K
BEKE icon
2999
KE Holdings
BEKE
$19.7B
-36,200
Closed -$587K
BIAF icon
3000
bioAffinity Technologies
BIAF
$3.15M
-48
Closed -$31.8K

Similar funds

John Overdeck's Q1 2024 Portfolio in Review

As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, John Overdeck opened a new position in Pfizer worth $234M.

  • John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
  • John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
  • John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
  • John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
  • John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
  • John Overdeck opened 408 new positions and closed 532 in Q1 2024.
  • John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.